United States · FDA National Drug Code directory
JANUMET
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-0575_61bde692-38c6-42dc-aaac-503cc7e1d8f8
- Product NDC
- 0006-0575
- Form
- TABLET, FILM COATED
- Composition / generic term
- SITAGLIPTIN and METFORMIN HYDROCHLORIDE
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070330
- Source listing expiry
- 20271231
Source-listed ingredients
- SITAGLIPTIN PHOSPHATE — 50 mg/1
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BOTTLE in 1 CARTON (0006-0575-03) / 14 TABLET, FILM COATED in 1 BOTTLE (0006-0575-02) · 0006-0575-03
- 4 POUCH in 1 CARTON (0006-0575-56) / 2 BLISTER PACK in 1 POUCH / 7 TABLET, FILM COATED in 1 BLISTER PACK · 0006-0575-56
- 60 TABLET, FILM COATED in 1 BOTTLE (0006-0575-61) · 0006-0575-61
- 180 TABLET, FILM COATED in 1 BOTTLE (0006-0575-62) · 0006-0575-62
- 1000 TABLET, FILM COATED in 1 BOTTLE (0006-0575-82) · 0006-0575-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →